$2.12
-0.02 (-0.93%)
Open$2.14
Previous Close$2.14
Day High$2.14
Day Low$2.09
52W High$5.59
52W Low$2.86
Volume—
Avg Volume66.8K
Market Cap282.06M
P/E Ratio—
EPS$-0.52
SectorPharmaceuticals
Analyst Ratings
Strong Buy
9 analysts
Price Target
+1,730.7% upside
Current
$2.12
$2.12
Target
$38.81
$38.81
$30.55
$38.81 avg
$50.01
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 961.68M | 811.47M | 117.29M |
| Net Income | -82,157,576 | -62,392,893 | 15.94M |
| Profit Margin | -8.5% | -8.1% | 13.6% |
| EBITDA | 6.56M | 5.26M | 20.19M |
| Free Cash Flow | — | — | 10.06M |
| Rev Growth | +18.5% | +18.5% | +17.8% |
| Debt/Equity | 1.25 | 1.25 | 1.32 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |